Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea

Salix Pharmaceuticals announced that it has submitted to the FDA a new drug application for Crofelemer for the proposed treatment of HIV-associated diarrhea.
MarketWatch